Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Pharmaceuticals found liable for role in New York opioid epidemic - UPI.com
Israel-based Teva settles opioid lawsuit with San Francisco for $45M
Opioid Manufacturer Teva Pharmaceuticals Reaches $4B Global Settlement | Law.com
Teva firing 350 employees from Israeli production facility | Ctech
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Israel targets Teva over MS drug royalties
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
These Israeli pharmaceutical stocks are down in the wake of Hamas attack - MarketWatch
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva boss hits out at opioid lawsuits
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
An Israeli pharma champion sickens
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Pharmaceuticals at heart of major price fixing suit in US – www.israelhayom.com
InnovationRx: Israel Makes Up 8% Of Teva's Global Production
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
